Over the last decade there have been multiple controversies which have damaged the reputation of ‘Big Pharma’ in the eyes of the general public.
However, the pharmaceutical industry’s response to COVID-19 , and subsequent rapid vaccine development are now considered essential to securing a way out of cyclical lockdowns and reopening economies.
The “2020 Global pharma study” from Caliber affirms “Now, as the pubic eye turns towards Big Pharma for a vaccine for COVID-19, the industry has been given a rare opportunity to prove its relevance. If this opportunity is taken, a whole new relationship with society may follow: one that sees patients, employees, physicians, organizations and governments being more supportive and less critical. One that solidifies the pharmaceutical companies sector’s legitimacy, ensures its future success and enables it to fulfill its true role of improving lives and livelihoods.”
In January 2021, we have conducted an internal survey amongst 1,096 healthcare professionals working in the United Kingdom, Germany, France, Spain, and Italy. We asked our panel members if the rapid rollout of vaccines has helped to improve perceptions of the pharmaceutical industry and pharmaceutical companies.
Here is what the M3 Global Community thinks about this topic.
“Vaccines and perception of the pharmaceutical industry” is one of the many topics we cover, you can visit our available studies section and discover all the paid opportunities available for your specialty.
By joining M3 Global Research, you will be able to have your voice heard. Taking part in market research is easy and you will receive an incentive for your precious time.
We are looking for opinions from healthcare professionals as well as caregivers and the general public to improve future patient outcomes.